Therapeutic Asset Ratings
13,155 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Balstilimab
Colon Carcinoma
City of Hope Medical Center
P2
B
(60)
Bebt-908 For
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
BeBetter Med Inc
P2
B
(60)
Belzutifan
Clear Cell Renal Carcinoma
José Claudio Casali da Rocha
P2
B
(60)
Bendamustine
Primary Central Nervous System Lymphoma
Miltenyi Biomedicine GmbH
P2
B
(60)
Bendamustine
B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma And Classical Hodgkin Lymphoma
UNC Lineberger Comprehensive Cancer Center
P2
B
(60)
Bendamustine
Lymphatic System Disorder
UNC Lineberger Comprehensive Cancer Center
P2
B
(60)
Bendamustine
Myelodysplastic Syndrome
St. Petersburg State Pavlov Medical University
P2
B
(60)
Berzosertib
Fallopian Tube Carcinoma
National Cancer Institute (NCI)
P2
B
(60)
Berzosertib
Ovarian Carcinoma
National Cancer Institute (NCI)
P2
B
(60)
Berzosertib
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)
P2
B
(60)
Bet Bromodomain Inhibitor Zen-3694
Triple-Negative Breast Carcinoma
National Cancer Institute (NCI)
P2
B
(60)
Bet Bromodomain Inhibitor Zen-3694
Prostate Cancer
Rahul Aggarwal
P2
B
(60)
Bexotegrast
Idiopathic Pulmonary Fibrosis
Pliant Therapeutics, Inc.
P2
B
(60)
Binimetinib
Breast Cancer
National Cancer Institute (NCI)
P2
B
(60)
Blinatumomab
Acute Myeloid Leukemia With BCR-ABL1
M.D. Anderson Cancer Center
P2
B
(60)
Blinatumomab
B-Cell Childhood Acute Lymphoblastic Leukemia
Seoul National University Hospital
P2
B
(60)
Blinatumomab
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Marlise Luskin, MD
P2
B
(60)
Blinatumomab
Non-Hodgkin Lymphoma
St. Jude Children's Research Hospital
P2
B
(60)
bnt327
Breast Cancer
BioNTech SE
P2
B
(60)
Bortezomib
Smoldering Plasma Cell Myeloma
Omar Nadeem, MD
P2
B
(60)
Bortezomib
Burkitt Lymphoma
Rutgers, The State University of New Jersey
P2
B
(60)
Boserolimab
Triple-Negative Breast Carcinoma
Merck Sharp & Dohme LLC
P2
B
(60)
Botensilimab
Colon Adenocarcinoma
City of Hope Medical Center
P2
B
(60)
Botensilimab
Colorectal Carcinoma
City of Hope Medical Center
P2
B
(60)
Botensilimab
Rectum Adenocarcinoma
City of Hope Medical Center
P2
B
(60)
Showing 1601 to 1625 of 13,155 assets
Previous
Page 65 of 527
Next